The FDA Oncology Center of Excellence made a statement regarding patients with cancer during the coronavirus disease 2019 (COVID-19) pandemic.1
Though the virus is interrupting everyone’s daily lives, the impact could be hardest on those with acute or chronic medical conditions and those with weakened immune systems, such as that caused by cancer and some cancer treatments, such as chemotherapy.
“In this critical time, we want you to know that we are here for patients with cancer and their health care providers and we will do everything we can to help you through this difficult period,” the FDA wrote. “Although our nation’s emphasis is on the need to combat this virus, patients with cancer and their unique needs continue to be a top priority.”
Current priorities working to address critical issues for this patient population include:
- Coordinating with drug developers,…
